Molecular Cell Previews Resemble and Inhibit : When RLR Meets TGF-b
Shu Zhu,Hua-Bing Li,Richard A. Flavell
2014-01-01
Abstract:TGF-b is a critical regulator of cell proliferation, differentiation, and development. In general, TGF-b signaling is initiated by ligand-induced oligomerization of serine/ threonine receptor kinases TGFRI/II. This is followed by the phosphorylation of the cytoplasmic signaling molecules Smad2 and Smad3, which results in their binding to the common signaling transducer Smad4, and translocation to the nucleus. Activated Smads regulate diverse gene expression and biological effects by partnering with transcription factors such as CBP/p300, GRIP1, and AP-1, resulting in cell-state specificmodulation of transcription (Flavell et al., 2010; Li and Flavell, 2008) (Figure 1). The recognition of microbial-derived nucleic acids and the activation of the molecular machinery governing the mammalian immune response are paramount to host survival during viral infection. Viral RNA represents a key trigger to the activation and mobilization of a series of pattern recognition receptors (PRRs) such as the Toll-like receptor (TLR) and RLR families. Upon viral dsRNA ligation, RIG-I propagates signal transduction via interactions with MAVS. Such functional aggregates are capable of recruiting key downstream signaling components, resulting in the activation of the mitogen and stress-activated protein kinases (MAPKs), the NF-kB pathway, and interferon regulatory factor 3/7 (IRF3/7), which culminates in the upregulation of protective type I interferons (IFNs) and pro-inflammatory cytokines (Kawai and Akira, 2008; Loo and Gale, 2011) (Figure 1). It is interesting to consider how innate antiviral signaling like RLR or TLR could control TGF-b signaling, allowing cells to respond to a variety of pro-inflammatory stimuli more efficiently. In this issue, Xu et al., (2014) show that RLR-activated IRF3 both prevents association of Smad3 with TGFbR and prevents functional Smad transcriptonal complex formation (Xu et al., 2014) (Figure 1). Transfection of poly (I:C) RNA (TpIC) can activate IRF3 by C-terminal phosphorylation through RIG-I-like receptors (RLRs) (Fitzgerald et al., 2003; Sharma et al., 2003). Surprisingly, Xu and colleagues found this activation inhibits TGF-b-induced transcription of a Smad3 luciferase reporter, as well as endogenous Samd7 and c-Myc expression (Xu et al., 2014). In addition, they show that inhibition of IRF3 phosphorylation, or knockdown of IRF3, can reverse the RLR-mediated suppression of the TGF-b pathway. They further found that a constitutive active form of IRF3 (IRF3 5SD), but not wild-type unphosphorylated IRF3, mediated a striking repression of TGF-b/ Smad3-activated transcription of reporters and endogenous target genes. The authors then investigated how activated IRF3 inhibits TGF-b/Smad3 pathway. They first excluded the possibility of indirect suppression through IRF3 target genes. They then considered whether activated IRF3 either directly inhibits Smad3 activation in the cytoplasm or interferes with Smad3 binding to its target genes in the nucleus. Interestingly, IRF3 and Smad3 have strikingly similar protein structures, and both are activated via C-terminal phosphorylation, which initiates multimerization, suggesting that IRF3 may compete with Smad3 (Chacko et al., 2004; Qin et al., 2003; Takahasi et al., 2003). Indeed, Xu et al. (2014) found that wild-type IRF3 interacts with Smad4, but once activated by TpIC, the phosphorylated IRF3 associates with non-acti-